Cargando…

Validation of High Resolution Melting Analysis (HRM) of the Amplified ITS2 Region for the Detection and Identification of Yeasts from Clinical Samples: Comparison with Culture and MALDI-TOF Based Identification

AIM: Candida species are known as opportunistic pathogens, and a possible cause of invasive infections. Because of their species-specific antimycotic resistance patterns, reliable techniques for their detection, quantification and identification are needed. We validated a DNA amplification method fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Duyvejonck, Hans, Cools, Piet, Decruyenaere, Johan, Roelens, Kristien, Noens, Lucien, Vermeulen, Stefan, Claeys, Geert, Decat, Ellen, Van Mechelen, Els, Vaneechoutte, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546670/
https://www.ncbi.nlm.nih.gov/pubmed/26295947
http://dx.doi.org/10.1371/journal.pone.0132149
_version_ 1782386967221108736
author Duyvejonck, Hans
Cools, Piet
Decruyenaere, Johan
Roelens, Kristien
Noens, Lucien
Vermeulen, Stefan
Claeys, Geert
Decat, Ellen
Van Mechelen, Els
Vaneechoutte, Mario
author_facet Duyvejonck, Hans
Cools, Piet
Decruyenaere, Johan
Roelens, Kristien
Noens, Lucien
Vermeulen, Stefan
Claeys, Geert
Decat, Ellen
Van Mechelen, Els
Vaneechoutte, Mario
author_sort Duyvejonck, Hans
collection PubMed
description AIM: Candida species are known as opportunistic pathogens, and a possible cause of invasive infections. Because of their species-specific antimycotic resistance patterns, reliable techniques for their detection, quantification and identification are needed. We validated a DNA amplification method for direct detection of Candida spp. from clinical samples, namely the ITS2-High Resolution Melting Analysis (direct method), by comparing it with a culture and MALDI-TOF Mass Spectrometry based method (indirect method) to establish the presence of Candida species in three different types of clinical samples. MATERIALS AND METHODS: A total of 347 clinical samples, i.e. throat swabs, rectal swabs and vaginal swabs, were collected from the gynaecology/obstetrics, intensive care and haematology wards at the Ghent University Hospital, Belgium. For the direct method, ITS2-HRM was preceded by NucliSENS easyMAG DNA extraction, directly on the clinical samples. For the indirect method, clinical samples were cultured on Candida ID and individual colonies were identified by MALDI-TOF. RESULTS: For 83.9% of the samples there was complete concordance between both techniques, i.e. the same Candida species were detected in 31.1% of the samples or no Candida species were detected in 52.8% of the samples. In 16.1% of the clinical samples, discrepant results were obtained, of which only 6.01% were considered as major discrepancies. Discrepancies occurred mostly when overall numbers of Candida cells in the samples were low and/or when multiple species were present in the sample. DISCUSSION: Most of the discrepancies could be decided in the advantage of the direct method. This is due to samples in which no yeast could be cultured whereas low amounts could be detected by the direct method and to samples in which high quantities of Candida robusta according to ITS2-HRM were missed by culture on Candida ID agar. It remains to be decided whether the diagnostic advantages of the direct method compensate for its disadvantages.
format Online
Article
Text
id pubmed-4546670
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-45466702015-09-01 Validation of High Resolution Melting Analysis (HRM) of the Amplified ITS2 Region for the Detection and Identification of Yeasts from Clinical Samples: Comparison with Culture and MALDI-TOF Based Identification Duyvejonck, Hans Cools, Piet Decruyenaere, Johan Roelens, Kristien Noens, Lucien Vermeulen, Stefan Claeys, Geert Decat, Ellen Van Mechelen, Els Vaneechoutte, Mario PLoS One Research Article AIM: Candida species are known as opportunistic pathogens, and a possible cause of invasive infections. Because of their species-specific antimycotic resistance patterns, reliable techniques for their detection, quantification and identification are needed. We validated a DNA amplification method for direct detection of Candida spp. from clinical samples, namely the ITS2-High Resolution Melting Analysis (direct method), by comparing it with a culture and MALDI-TOF Mass Spectrometry based method (indirect method) to establish the presence of Candida species in three different types of clinical samples. MATERIALS AND METHODS: A total of 347 clinical samples, i.e. throat swabs, rectal swabs and vaginal swabs, were collected from the gynaecology/obstetrics, intensive care and haematology wards at the Ghent University Hospital, Belgium. For the direct method, ITS2-HRM was preceded by NucliSENS easyMAG DNA extraction, directly on the clinical samples. For the indirect method, clinical samples were cultured on Candida ID and individual colonies were identified by MALDI-TOF. RESULTS: For 83.9% of the samples there was complete concordance between both techniques, i.e. the same Candida species were detected in 31.1% of the samples or no Candida species were detected in 52.8% of the samples. In 16.1% of the clinical samples, discrepant results were obtained, of which only 6.01% were considered as major discrepancies. Discrepancies occurred mostly when overall numbers of Candida cells in the samples were low and/or when multiple species were present in the sample. DISCUSSION: Most of the discrepancies could be decided in the advantage of the direct method. This is due to samples in which no yeast could be cultured whereas low amounts could be detected by the direct method and to samples in which high quantities of Candida robusta according to ITS2-HRM were missed by culture on Candida ID agar. It remains to be decided whether the diagnostic advantages of the direct method compensate for its disadvantages. Public Library of Science 2015-08-21 /pmc/articles/PMC4546670/ /pubmed/26295947 http://dx.doi.org/10.1371/journal.pone.0132149 Text en © 2015 Duyvejonck et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Duyvejonck, Hans
Cools, Piet
Decruyenaere, Johan
Roelens, Kristien
Noens, Lucien
Vermeulen, Stefan
Claeys, Geert
Decat, Ellen
Van Mechelen, Els
Vaneechoutte, Mario
Validation of High Resolution Melting Analysis (HRM) of the Amplified ITS2 Region for the Detection and Identification of Yeasts from Clinical Samples: Comparison with Culture and MALDI-TOF Based Identification
title Validation of High Resolution Melting Analysis (HRM) of the Amplified ITS2 Region for the Detection and Identification of Yeasts from Clinical Samples: Comparison with Culture and MALDI-TOF Based Identification
title_full Validation of High Resolution Melting Analysis (HRM) of the Amplified ITS2 Region for the Detection and Identification of Yeasts from Clinical Samples: Comparison with Culture and MALDI-TOF Based Identification
title_fullStr Validation of High Resolution Melting Analysis (HRM) of the Amplified ITS2 Region for the Detection and Identification of Yeasts from Clinical Samples: Comparison with Culture and MALDI-TOF Based Identification
title_full_unstemmed Validation of High Resolution Melting Analysis (HRM) of the Amplified ITS2 Region for the Detection and Identification of Yeasts from Clinical Samples: Comparison with Culture and MALDI-TOF Based Identification
title_short Validation of High Resolution Melting Analysis (HRM) of the Amplified ITS2 Region for the Detection and Identification of Yeasts from Clinical Samples: Comparison with Culture and MALDI-TOF Based Identification
title_sort validation of high resolution melting analysis (hrm) of the amplified its2 region for the detection and identification of yeasts from clinical samples: comparison with culture and maldi-tof based identification
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546670/
https://www.ncbi.nlm.nih.gov/pubmed/26295947
http://dx.doi.org/10.1371/journal.pone.0132149
work_keys_str_mv AT duyvejonckhans validationofhighresolutionmeltinganalysishrmoftheamplifiedits2regionforthedetectionandidentificationofyeastsfromclinicalsamplescomparisonwithcultureandmalditofbasedidentification
AT coolspiet validationofhighresolutionmeltinganalysishrmoftheamplifiedits2regionforthedetectionandidentificationofyeastsfromclinicalsamplescomparisonwithcultureandmalditofbasedidentification
AT decruyenaerejohan validationofhighresolutionmeltinganalysishrmoftheamplifiedits2regionforthedetectionandidentificationofyeastsfromclinicalsamplescomparisonwithcultureandmalditofbasedidentification
AT roelenskristien validationofhighresolutionmeltinganalysishrmoftheamplifiedits2regionforthedetectionandidentificationofyeastsfromclinicalsamplescomparisonwithcultureandmalditofbasedidentification
AT noenslucien validationofhighresolutionmeltinganalysishrmoftheamplifiedits2regionforthedetectionandidentificationofyeastsfromclinicalsamplescomparisonwithcultureandmalditofbasedidentification
AT vermeulenstefan validationofhighresolutionmeltinganalysishrmoftheamplifiedits2regionforthedetectionandidentificationofyeastsfromclinicalsamplescomparisonwithcultureandmalditofbasedidentification
AT claeysgeert validationofhighresolutionmeltinganalysishrmoftheamplifiedits2regionforthedetectionandidentificationofyeastsfromclinicalsamplescomparisonwithcultureandmalditofbasedidentification
AT decatellen validationofhighresolutionmeltinganalysishrmoftheamplifiedits2regionforthedetectionandidentificationofyeastsfromclinicalsamplescomparisonwithcultureandmalditofbasedidentification
AT vanmechelenels validationofhighresolutionmeltinganalysishrmoftheamplifiedits2regionforthedetectionandidentificationofyeastsfromclinicalsamplescomparisonwithcultureandmalditofbasedidentification
AT vaneechouttemario validationofhighresolutionmeltinganalysishrmoftheamplifiedits2regionforthedetectionandidentificationofyeastsfromclinicalsamplescomparisonwithcultureandmalditofbasedidentification